Precigen (PGEN) EPS (Basic) (2016 - 2025)

Precigen (PGEN) has disclosed EPS (Basic) for 14 consecutive years, with -$1.09 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Basic) fell 1111.11% to -$1.09 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.42, a 158.18% decrease, with the full-year FY2024 number at -$0.47, down 20.51% from a year prior.
  • EPS (Basic) was -$1.09 for Q3 2025 at Precigen, down from -$0.09 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.04 in Q4 2021 to a low of -$1.09 in Q3 2025.
  • A 5-year average of -$0.16 and a median of -$0.1 in 2021 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): skyrocketed 81.82% in 2021, then crashed 1111.11% in 2025.
  • Precigen's EPS (Basic) stood at -$0.04 in 2021, then plummeted by 175.0% to -$0.11 in 2022, then dropped by 18.18% to -$0.13 in 2023, then surged by 53.85% to -$0.06 in 2024, then crashed by 1716.67% to -$1.09 in 2025.
  • Per Business Quant, the three most recent readings for PGEN's EPS (Basic) are -$1.09 (Q3 2025), -$0.09 (Q2 2025), and -$0.18 (Q1 2025).